These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2840801)

  • 1. Defective killer cell activity in patients with chronic active Epstein-Barr virus infection.
    Wakiguchi H; Fujieda M; Matsumoto K; Ohara Y; Wakiguchi A; Kurashige T
    Acta Med Okayama; 1988 Jun; 42(3):137-42. PubMed ID: 2840801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection.
    Yanagisawa M; Kato M; Ikeno K; Kobayashi T; Miyagawa Y; Komiyama A; Akabane T
    Clin Exp Immunol; 1987 May; 68(2):251-8. PubMed ID: 2820633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic effector cells from infectious mononucleosis patients in the acute phase do not specifically kill Epstein-Barr virus genome-carrying lymphoid cell lines.
    Patel PC; Dorval G; Menezes J
    Infect Immun; 1982 Oct; 38(1):251-9. PubMed ID: 6292093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunological studies on chronic active Epstein-Barr virus infection in children--low spontaneous cytotoxicity and lymphokine augmented spontaneous cytotoxicity against Raji cells].
    Wakiguchi H; Fujieda M; Matsumoto K; Kurashige T
    Arerugi; 1989 Feb; 38(2):98-103. PubMed ID: 2751430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic mechanisms in vitro against Epstein-Barr virus infected lymphoblastoid cell lines in rheumatoid arthritis.
    McChesney MB; Bankhurst AD
    Ann Rheum Dis; 1986 Jul; 45(7):546-52. PubMed ID: 3017244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood lymphocytes resistant to Epstein-Barr virus immortalization manifest high natural killer (NK) type activity against NK-resistant target cells.
    Gosselin J; Menezes J; Mercier G; Lamoureux G; Oth D
    Viral Immunol; 1990; 3(1):55-65. PubMed ID: 2153385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line.
    Rickinson AB; Moss DJ; Allen DJ; Wallace LE; Rowe M; Epstein MA
    Int J Cancer; 1981 May; 27(5):593-601. PubMed ID: 6169663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation with autologous lymphoblastoid cell lines: lysis of Epstein-Barr virus-positive and -negative cell lines by two phenotypically distinguishable effector cell populations.
    Zarling JM; Dierckins MS; Sevenich EA; Clouse KA
    J Immunol; 1981 Nov; 127(5):2118-23. PubMed ID: 6170690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
    Strang G; Rickinson AB
    Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective immune response to Epstein-Barr virus in patients with acute lymphocytic leukemia.
    Wakiguchi H; Fujieda M; Matsumoto K; Ohara Y; Wakiguchi A; Kurashige T
    Acta Paediatr Jpn; 1989 Apr; 31(2):144-9. PubMed ID: 2560606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
    Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis.
    Wang F; Blaese RM; Zoon KC; Tosato G
    J Clin Invest; 1987 Jan; 79(1):7-14. PubMed ID: 3025263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8high (CD57+) T cells in normal, healthy individuals specifically suppress the generation of cytotoxic T lymphocytes to Epstein-Barr virus-transformed B cell lines.
    Wang EC; Lehner PJ; Graham S; Borysiewicz LK
    Eur J Immunol; 1994 Nov; 24(11):2903-9. PubMed ID: 7525311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
    Masucci MG; Szigeti R; Ernberg I; Masucci G; Klein G; Chessels J; Sieff C; Lie S; Glomstein A; Businco L; Henle W; Henle G; Pearson G; Sakamoto K; Purtilo DT
    Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis.
    Svedmyr E; Jondal M
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1622-6. PubMed ID: 165518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro.
    Moss DJ; Wallace LE; Rickinson AB; Epstein MA
    Eur J Immunol; 1981 Sep; 11(9):686-93. PubMed ID: 6170517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis.
    Royston I; Sullivan JL; Periman PO; Perlin E
    N Engl J Med; 1975 Dec; 293(23):1159-63. PubMed ID: 171568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effects of infusing anti-Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes into patients with severe chronic active EBV infection.
    Hagihara M; Tsuchiya T; Hyodo O; Ueda Y; Tazume K; Masui A; Kanemura A; Yoshiba F; Takashimizu S; Matzusaki S; Kato S; Hotta T
    Int J Hematol; 2003 Jul; 78(1):62-8. PubMed ID: 12894853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ex vivo inducing cultured Epstein-Barr virus specific cytotoxic T lymphocytes and evaluation of their killing effect].
    Chen GH; Gu B; Chen F; Wang Y; Qiao M; Liu HW; Feng YF; Dai LJ; Zhu ZL; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1597-601. PubMed ID: 24370055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.
    Sugaya N; Kimura H; Hara S; Hoshino Y; Kojima S; Morishima T; Tsurumi T; Kuzushima K
    J Infect Dis; 2004 Sep; 190(5):985-8. PubMed ID: 15295706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.